Aurion Biotech

Aurion is proud to support the life-changing work performed by our eye-banking partners.

Fantastic news for Aurion. We welcome Dr. Holland as our Chief Medical Officer, and are thrilled for Eris Jordan's promotion to Chief Development Officer. Together this team will continue to do amazing things for patients! https://lnkd.in/gsNHwAkv

Important, exciting news for patients suffering from corneal endothelial disease: https://lnkd.in/gBTe683Z

Aurion is #4 in Fast Company's Most Innovative Companies: Medicines / Therapeutics / Pharma Category! https://lnkd.in/g9JBENNa

We are delighted that Don Munoz has joined as CFO! https://lnkd.in/gxTXi7nt

As we near the shortest day of the year, we're happy to share a long list of gratitude for tireless work, managing complex logistics, endless patience and smooth coordination. Thanks to the CLARA trial investigators and their amazing teams, their wonderful patients, and our own Aurionians for getting us to today's news! https://lnkd.in/g-SWTBxT

Thanks to Biotech Breakthrough for awarding us Regenerative Therapeutics Company of the year! https://lnkd.in/ehus6F-7

Our inventor, Prof. Shigeru Kinoshita, presenting one of his first cases, now 9 years post-op, here at AAO. Remarkable!

For millions of patients suffering from corneal endothelial disease, today is a good day: we launched in Japan! Huge thanks to our brilliant and wonderful inventor, Prof. Shigeru Kinoshita. https://lnkd.in/g4FD8esY

here at Biotech Week Boston awards dinner with a mighty fine team!!